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Abstract
Impairment of neuromuscular function in neurological disorders leads to reductions in muscle force, which may lower
quality of life. Rehabilitation robots that are equipped with sensors are able to quantify the extent of muscle force
impairment and to monitor a patient during the process of neurorehabilitation with sensitive and objective assessment
methods. In this article, we provide an overview of fundamental aspects of muscle function and how the
corresponding variables can be quantified by means of meaningful robotic assessments that are primarily oriented
towards upper limb neurorehabilitation. We discuss new concepts for the assessment of muscle function, and present
an overview of the currently available systems for upper limb measurements. These considerations culminate in
practical recommendations and caveats for the rational quantification of force magnitude, force direction, moment of a
force, impulse, critical force (neuromuscular fatigue threshold) and state and trait levels of fatigue.
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Background
This work was developed in the frame of the project
“State of the Art Robot-Supported assessments (STARS)”
as part of the COST Action TD1006 “European Network
on Robotics for NeuroRehabilitation” [1]. STARS is
intended to equally serve clinical practitioners and scien-
tists working in the field of neurorehabilitation. The goal
is to give recommendations for development, implemen-
tation, and administration of different indices of robotic
assessments, grounded on the scientific literature avail-
able at this time.
Intact neuromuscular function is indispensable for
motor function, activities of daily living and social par-
ticipation [2]. Neurological disorders can result in severe
impairment of neuromuscular function. In stroke, the
muscular weakness results from changes in muscle mass,
length, muscle architecture (e.g., pennation angle)
muscle composition (i.e., fiber type, fat content, connect-
ive tissue) and material properties [3]. Furthermore, an
increase in stretch reflex excitability, antagonist muscle
coactivation, and a decrease in motor unit firing rate are
observed [4]. Sufficient force in the upper limb is related
to the ability to adequately perform many activities of
daily living [2], and regaining muscle force is a major
goal in upper extremity neurorehabilitation. Further-
more, grip strength is a major predictor of recovery and
all-cause mortality [5, 6]. To provide optimal therapy,
valid, reliable, sensitive, and standardized assessment
methods are crucial as they serve to quantify the extent
of impairment, to identify the most effective and time ef-
ficient training and to progressively adapt the therapy
(exercise type, intensity and time commitment) to the
individual’s progress, needs and goals.
Force assessments with either quantitative or more
qualitative methods is an integral part of the physical
examination in neurorehabilitation such as stroke [7] or
spinal cord injury (SCI, [8]). The manual muscle test
(MMT) is the most frequently used clinical assessment.
It is integrated in the international standards for neuro-
logical classification of spinal cord injury [8]. It is classi-
fied as a semi-quantitative method with relatively low
accuracy and sensitivity. Isometric force of individual
muscles and muscle groups is subjectively rated based
on the effective performance of a movement against
gravity or resistance applied by an examiner. A number
of grading systems exist for manual muscle testing [9–
11]. Quantification of force or moment with continuous
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variables requires instrumentation. A common method
in clinical practice is isometric dynamometry with a
handheld dynamometer [12]. It has good reliability and
it is sensitive for all grades. Furthermore, it is less
dependent on technique than the MMT, but it is not
suitable when movement against resistance cannot be
performed. Isometric dynamometry can be integrated in
clinical tests (e.g., the Wolf Motor Function Test [13]).
Novel and rapidly expanding technologies such as re-
habilitation robotics can provide objective quantification
of neuromuscular function in a standardized way. This
may help to overcome the common limitations of clin-
ical assessments [14], and advance the development of
personalized human-machine interfaces alongside as-
sessments and rehabilitation interventions that are tai-
lored to a specific patient’s anatomy and neurological
disorder. Attempts have been made to correlate robotic
mechanical variables with established clinical scores
based on the International Classification of Functioning,
Disability and Health (ICF, http://www.who.int/classifi-
cations/icf/en/) [14]. In this article, we will present rec-
ommendations for the design and application of robotic
assessments of muscle force in the field of upper limb
neurorehabilitation. The major aim of this paper is not
to present rigorous mathematical descriptions of already
existing assessment methods but rather to identify the
relevant practical and theoretical concepts of muscle
physiology that should underlie all robotic assessments
of muscle function and to highlight the various manifes-
tations of muscle force exertion that need to be quanti-
fied. We will restrict our work on electromechanical and
robot-assisted devices; additional means such as electro-
myogram (EMG) are discussed in the context of neuro-
mechanical interplay.
Review
Definition of measurements of strength
The function of skeletal muscle and its neural control
The colloquial term “strength” usually refers to the SI-
entities mass, force, moment or power. In the context of
human movement, the function of muscle is to exert
force and it does so by acting either exclusively or in
combination on shortening or lengthening the muscle-
tendon unit or by keeping its length quasi-constant. For
the purpose of this review we will refer to these three
modes of force exertion as being miometric, pliometric,
and isometric, respectively [15]. The neural control strat-
egies underlying these modes of muscle action can differ.
Whereas the recruitment order of motor units is similar
during submaximal miometric and pliometric actions
and consistent with the size principle of motor unit re-
cruitment, the discharge rate is systematically lower dur-
ing pliometric actions as compared to miometric actions
[16–19]. Furthermore, untrained individuals are usually
unable to fully activate their muscles despite a maximal
intended pliometric action [20, 21]. In order to pinpoint
muscle function deficits to neural impairments, it might
be valuable to assess muscle function for the three types
of force exertion modes separately and in combination.
Robotic systems for strength measurement
Isokinetic dynamometers
The clinical gold standard for the assessment of muscu-
loskeletal performance is the isokinetic (isokinetic for
“same motion”) dynamometer (ID). IDs are devices that
measure joint moment while maintaining a constant
joint velocity or rather a constant angular velocity of the
machine’s lever against which muscle action occurs. The
ID movements are two-dimensional and rotational
around a joint. The way for creating moment may be hy-
draulic, frictional or electro-magnetic and the angle-
moment curves between these systems may differ con-
siderably [22]. Most devices allow also for isometric
measurements.
Although ID measurements are sensitive, reproducible,
and can contribute valuable information, there are a
number of caveats that concern the validity of interpre-
tations from “isokinetic” assessment results:
1.) In spite of the fact that angular velocity is kept
constant during isokinetic assessments, muscle fiber
velocity is not constant throughout the range of
motion (ROM), especially at higher velocities [23].
This is due to various factors, such as variable
muscle moment arm, variable tendon compliance,
and variable muscle activation throughout the ROM.
2.) The term “isokinetic” refers to the angular velocity
of the device and not to muscle fiber or limb
velocity [24], and, although IDs control for velocity,
phases of accelerations, oscillations and
decelerations limit the periods of constant angular
velocity [25].
3.) Angular velocity of many “normal” activities is clearly
beyond the maximal angular velocity (~5.24 rad/s, i.e.
~ 300°/s) of typical isokinetic devices. For instance,
humeral internal rotation velocity during throwing
(overhand pitching) may reach 130–134 rad/s and
knee and ankle angular velocity during jumping is
about 12–15 rad/s [26–28].
4.) The typically employed miometric actions on an ID
cannot a priori yield maximal force values [29].
Pliometric actions on an ID cannot yield maximal
moment values either, because the moment record
itself is often of shorter duration than the time
required to accomplish complete muscle fiber
activation. Even for isometric actions it takes at least
400–700 ms up to several seconds to reach peak
moment [30, 31].
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5.)Movement in an ID requires both spatial and
temporal coordination. The movement direction in
IDs defines only the path of the attached part of the
limb (e.g., the hand). Although being planar, several
muscles and muscle compartments have to be
recruited by neurons in a coordinated, timed manner.
Thus, a low magnitude in the resulting force
(especially during fast movements) could be
misinterpreted as muscle weakness, when indeed the
low force is caused by suboptimal force directions and
decreased temporospatial coordination due to
neuronal deficits. It has to be emphasized that muscle
architecture changes with neurological deficits and
the recruitment required for a defined movement may
differ in patients from that of healthy subjects. Six-
axes sensors can detect forces from all three Cartesian
coordinates (x, y and z) and recognize deviations of
the force direction. The information may also be used
for smoothness assessments.
6.) The moments obtained using IDs are not the same
as the resultant joint moments. Gravitational
moments are a major source of error and must be
corrected for. They are usually modeled using sine
or cosine functions and can be corrected by either
subtracting (i.e., when working with gravity) or
adding (i.e., when working against gravity) the limb
weight [32]. Furthermore, passive elastic moments
contribute to the total joint moment. The term
describes the passive viscoelastic deformation
primarily by tissues crossing the joint, including the
muscles, the tendons and ligaments [32]. In the
shoulder, it can be used to store and release energy
(e.g., during throwing [33]).
7.) IDs measure the moment at their own axis and do not
account for the variation of the rotational axis of a joint
or misalignment of the limb with the lever arm, which
may additionally change during movement inertia.
Endeffector and exoskeleton robots for force assessments
Therapy robots are often equipped with force sensors for
quantifying interaction forces between the device and the
user. The devices provide raw sensor data about force dur-
ing functional movements and these data can be used to
extract complex pathology features such as abnormal syner-
gies [34]. Just as for the dynamometers, misalignment with
a device and variation of the rotational axis of a joint can
distort results. Furthermore, the subject has to interact with
the dynamics of the device, which includes joint friction,
mass and inertia, as well as backlash. Even with an online
adapting compensation, a robot will not achieve full trans-
parency. This may confound the results and even hamper
assessments in very weak patients. Several approaches in
both endeffector and exoskeleton robots were assessed in
healthy participants and patients:
MIME
The Mirror Image Movement Enabler (MIME) is a 6 de-
grees of freedom (DOF) endeffector robotic device for
shoulder and elbow neurorehabilitation. It is equipped
with a 6-axis force sensor that allows for unilateral and
bilateral training [35]. Modeled forearm trajectories were
used to control point to-point reaching movements in
the horizontal plane. The force direction error (FDE, see
“Force direction error”) was calculated during passive
and active-assisted movements. Furthermore, positive
work, potential work (defined as the work that would
have been done if the force magnitude was directed pre-
cisely in the movement direction and the torque magni-
tude was oriented precisely in the direction of rotation)
and work efficiency (the work done divided by the po-
tential work, had the total force been oriented toward
the target at all points along the path) were calculated.
ARM guide
The ARM Guide is an endeffector, linear robotic trainer
that can be oriented vertically on an elevation axis and
horizontally on a yaw axis across an individual’s work-
space. An arm splint slides along a linear track with a 6-
axis load cell measuring the forces and moments at the
interface between the patient and the device. It was used
to quantify pathological synergies in the arm [34]. To do
so, the “horizontal constraint force”, i.e., the force per-
pendicular to both the direction of movement and to the
gravity vector during reaching and retrieving task was
measured in hemiplegic patients [34]. Movements were
performed at peak speeds of 0.2 m/s and 0.8 m/s and at
two movement amplitudes (full ROM and 0.45 m).
BONES
The Biomimetic Orthosis for Neurorehabilitation of the
Elbow and Shoulder (BONES) is a 4 DOF, pneumatically-
actuated exoskeleton robot for arm neurorehabilitation
[36]. In a “coordinated strength measurement” with
BONES, patients post-stroke had to perform maximal
intended miometric muscle actions at the shoulder (ab-
duction/adduction, flexion/extension, internal/external ro-
tation), elbow (flexion/extension), forearm (pronation/
supination), and wrist (flexion/extension). The joint mo-
ment production in the desired as well as undesired direc-
tions was shown as online visual feedback to the
participant by means of the length of a bar. Deviation tol-
erance was set within a window that represented ±5° of
the desired joint position. The highest uncompensated
joint torque of 3 trials of each muscle action direction was
retained. A single score summarizing all 12 moment out-
come measures was then obtained through principle com-
ponent analysis (PCA) [37, 38].
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ARMin
ARMin is a 7 DOF exoskeleton robot for neurorehabil-
itation therapy of the arm. The device was used for iso-
metric moment assessment of the arm. The maximally
detectable joint moments of the motors were 59 N m
(elbow, shoulder rotation and horizontal movement) to
82 N m (arm elevation). ARMin moved the patient’s arm
in fixed predefined positions and held the position. Indi-
viduals were asked to apply maximal moment in the
joints being measured (arm elevation/retroversion, arm
abduction/adduction in the horizontal plane, elbow
flexion/extension) for 5 s. The measured joint moments
were derived from the motor current needed to hold the
patient’s arm in the defined position. A moving average
filter was applied to reduce the effect of single moment
peaks [39–41].
What to measure
In the following paragraphs we will discuss several basic
parameters that need to be specified, standardized, and
controlled during robotic force assessments to enable
scientific data acquisition, analysis, reporting, and com-
parison. To acquire the parameters, devices should be
equipped with sensors that measure time, position and
forces or moments.
Peak force
Under normal circumstances, internal muscle force can-
not be assessed directly in vivo in humans. It can only
be estimated from forward dynamics simulations or in-
verse dynamics techniques by using kinematic, kinetic
and EMG measurements in combination with computa-
tional modelling [42, 43].
Alternatively, the measured external contact force or mo-
ment caused by muscle actions can be used as proxy vari-
able for internal muscle force. External forces and
moments can be seen as a function of a patient’s neural
drive (i.e. the ensemble of action potentials of all active
motor neurons). At present, EMG represents the only non-
invasive methodology for interfacing indirectly with the
nervous system in patients [44]. Establishing relationships
between neural and mechanical variables has been ad-
dressed using model-free machine learning approaches (e.g.
[45]) and model-based methodologies (e.g. [46]). The latter
can be used to estimate internal neuromuscular and mech-
anical variables, such as muscle force (e.g. [42]), joint mo-
ment (e.g. [47]), joint compressive force (e.g. [48]), joint
stiffness (e.g. [49]), joint angles (e.g. [50]) or metabolic en-
ergy conversion (e.g. [51]) that otherwise could not be vi-
ably measured experimentally.
Since conventional bipolar EMG may provide impre-
cise muscle activation estimates and furthermore cannot
simultaneously provide estimates of activation in differ-
ent directions (e.g. medio-lateral vs. longitudinal) and
zones (distal vs. proximal), which is important in the
context of force or moment direction, the possibility of
employing high-density multichannel EMG should be
considered instead ([52]).
Because of the generic force-velocity relationship, the
highest force for a given motor task should result from a
maximal intended pliometric muscle action. As it takes at
least 400–700 ms up to several seconds to reach peak force
during a maximal intended isometric muscle action, we
propose to follow a 2 step procedure to assess peak force
for a given motor task (Fig. 1) [30, 31]. During the first step,
the performer reaches isometric peak force (IPF) during an
all-out effort at short (30% of peak active range of motion)
muscle-tendon length against the rigid and fixed robot arm.
Attaining isometric peak force may take up to several sec-
onds (2.5 s in the example in Fig. 1), depending among
other things on the magnitude of the attained force. The in-
dividual’s IPF is automatically detected by the robot. In the
second step, the robot smoothly increases its force in the
opposite direction while the performer tries to brake the
movement of the robot arm. As the robotic force increases,
the performer needs to increase the lengthening velocity
(Fig. 1, Step 2, A) in order to accommodate for the in-
creased robotic force until the point is reached, where the
force is velocity-independent (force plateau, P). For safety
reasons, the range of motion for the pliometric action
should be strictly controlled (i.e., to 60% of peak active
range of motion).
Another common procedure is to estimate a patient’s
strength as a function of joint angle. This is achieved
through sequential isometric actions over a certain range
of motion (ROM) that result in an angle-moment curve.
Such angle-moment curves should be used and inter-
preted with caution. In vivo, muscle force and moment
arm both change throughout the ROM, as does neural ac-
tivation. Hence, the joint angle where the moment of a
force reaches its highest value is not necessarily the joint
angle where either muscle force or moment arm are high-
est [53]. Furthermore, as the moment of a force around a
joint represents the interaction between muscle and joint
properties and because the exact relationship between the
joint angle-muscle and length-tension functions is un-
known for most muscles, the application of the generic
muscle length-tension curve to the in vivo assessment of a
patient’s muscle-joint system is questionable.
Force direction error
Force is a vector quantity in that it has both magnitude
and direction. Force direction is intrinsically linked to
the specific motor tasks of the activated muscles, which
in turn are mediated by the selective recruitment of
motor unit clusters. As a result of neuromuscular
compartmentalization, a single muscle can comprise sev-
eral distinct regions that each exert a different motor
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task. Consequently, depending on the type and severity
of the neural impairment, neurological patients (e.g.
after stroke) may lose independent control over single
neuromuscular compartments and muscles, and produce
an abnormal muscle (co-)activation pattern.
The resulting FDE describes the reduced ability to exert
force in the desired direction during motor task execution.
It can be defined as the angle between the force vector re-
corded by the sensors of the robotic device and the unit
vector aligned with the theoretical direction of movement.
The angle is calculated at each sampling point and aver-
aged across the trajectory [35, 54].
Similarly, FDE can be defined by the external mechan-
ical work. Perfect correspondence between a path direc-
tion (given by the assessment device) and the participant’s
movement direction occurs when the force vector compo-
nent perpendicular to the displacement is zero. This sce-
nario minimizes the force required to follow a path and
thus increases movement “smoothness”. Conversely, sub-
optimal directions of the actual forces may cause devia-
tions from a given trajectory during movements. Thus,
magnitude and direction of vector components gives in-
formation about movement control resulting from differ-
ential activation of neuromuscular compartments and the
underlying “smoothness” of a movement.
Critical force and fatigue
When the time of tolerance is plotted against particular
isometric maximal intended force or moment outputs,
the relationship is curvilinear, with the ability to exert
high force or moment falling away more sharply at
higher compared to lower forces or moments. Mathem-
atically, the force-duration relationship is described as
being hyperbolic. When exercise tolerance is considered,
the force-asymptote is called “critical force” (CF) [55].
Alongside with the peak force value and the curvature
constant obtained during the same test, CF provides an
index of critical neuromuscular fatigue threshold. The
same holds true for the assessment of critical moment
(CM).
We suggest to assess CF and CM by using a 5 min all-
out test following the protocol of Burnley [56]. The test
consists of 60 maximal intended isometric muscle ac-
tions using a 60% duty cycle (3 s force exertion, 2 s rest,
Fig. 2). Under these test conditions, the end-test mo-
ment (which corresponds to CM) occurs at approxi-
mately 30% of maximal intended isometric moment,
meaning that during the test the moment falls before
reaching stable values at approximately 30% of maximal
intended isometric moment [55, 56].
Interactions between performance fatigability (i.e., the
decline in an objective measure of performance, such as
force during a CF assessment) and perceived fatigability
(i.e., changes in the sensations that regulate the integrity
of the performer) specifically limit physical and cognitive
function and determine fatigue, and both need to be
assessed in order to define the neuromuscular state and
the specific psychobiological condition underlying the
force assessment [57, 58]. Perceived fatigability encom-
passes trait and state levels of fatigue, which can be
Fig. 1 Robotic assessment of the highest force for a given maximal intended force task. The two steps during the maximal intended force exertion of
the performer are denoted both in the generic length-tension relationship (a) and time-force relationship during the robotic assessment of peak force
(b). Step 1: the performer reaches isometric peak force (IPF) during an all-out effort at short (30% of peak range of motion) muscle-tendon length
against the rigid and fixed robot arm. Attaining isometric peak force may take up to several seconds (2.5 s in this example), depending among other
things on the magnitude of the attained force. Step 2: Immediately after attaining the individual’s IPF (automatically detected by the robot), the robot
smoothly increases its force in the opposite direction while the performer tries to brake the movement of the robot arm. As the robotic force increases,
the performer needs to increase the lengthening velocity (Step 2, A) in order to accomodate for the increased robotic force until the point is reached,
where the force is velocity-independent (force plateau, P). For safety reasons, the range of motion for the pliometric action should be strictly controlled
(to 60% of peak range of motion). Isometric, maximal intended isometric muscle action against fixed-position robotic exoskeleton; Pliometric, maximal
intended pliometric muscle action against the robot-imposed force increase above IPF
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assessed through scales and questionnaires that rely on
self-reported responses about the preceding several days
or weeks (trait level) and the measurement of fatigue at
a specific instant in time during a fatiguing task (state
level). The latter can be accomplished by asking the per-
former to instantaneously answer one or more questions
about the level of fatigue or to rate the perceived exer-
tion and pain during the exercise test. One instrument
often used to assess the state level of fatigue is the visual
analog scale [59].
Summarizing, the decline of force or moment with re-
peated isometric muscle actions (i.e., the performance fat-
igability), as characterized by the shape of the curve and
the end test force or moment (Fig. 2) can be used in con-
junction with the perceived fatigability to characterize the
fatigue characteristics of patients for both intra-subject
(e.g. affected vs. non-affected limb) and inter-subject (e.g.
patients vs. healthy individuals) comparisons.
Impulse or rate of force development
For short, high-intensity movements, the impulse-
generating capability of muscle is the key determining
factor of performance [60]. Consequently, impulse, or as
a proxy, the rate of force (or rate of moment) develop-
ment [RFD (RMD)], is a measure to characterize a pa-
tient’s or athlete’s “explosiveness” [61]. The impulse, that
is the force-time integral, is calculated from the force-
time curve for a specified time interval (i.e. at 50, 100,
150 ms from force onset). RFD is calculated as the slope
of the linear function F = f(t) from the force measure-
ments at specific points in time (i.e. at 50, 100, 150 ms
from force onset). From these measurements, either
overlapping (I0–50 ms, I0–100 ms, I0–150 ms and RFD0–50 ms,
RFD 0–100 ms, RFD0–150 ms for impulse and RFD,
respectively) or sequential (I0–50 ms, I50–100 ms, I100–150 ms
and RFD0–50 ms, RFD 50–100 ms, RFD100–150 ms for im-
pulse and RFD, respectively) calculations can be per-
formed. For the assessment of the “explosiveness” of a
patient’s movement through impulse (or RFD), we rec-
ommend to apply the practical considerations given by
Maffiuletti et al. [61].
We advise against using acceleration period data of
“isokinetic” miometric actions and derived parameters
such as torque acceleration energy (TAE) because they
are affected by the different velocity control mechanisms
of dynamometers used for assessment.
What is normal
Normative data (e.g. “reference” values) are popular for
classifying the patient’s muscle function relative to
healthy controls, for comparing muscle function in indi-
vidual patients or patient groups, to follow its natural
course in health and disease, and to assess the effective-
ness of therapeutic interventions. There exist normative
data for isokinetic moments of upper extremity muscle
groups [62–65]. However, when comparing individual
measurement results to normative data, several con-
founding variables such as age, gender, handedness and
muscle mass should be considered. Comparisons to the
contralateral muscles or limb, as well as agonist to an-
tagonist muscle groups may enable to detect imbalances
in pathologies.
The National Isometric Muscle Strength (NIMS) Data-
base Consortium established a normative database for
the population of the United States in 493 adult healthy
individuals by using 10 muscle groups [66]. Meldrum et
al. determined median and percentile predicted peak iso-
metric moment values stratified by age and gender for 9
muscle groups in 494 healthy individuals in Ireland [67].
Tawil et al. computed composite scores (Z scores) for
the assessment of patients suffering from facioscapulo-
humeral dystrophy (FSHD) based on the elbow flexion
moment determined in 32 healthy individuals [68]. This
normative database was enlarged to 168 healthy subjects
later on [69]. Hogrel et al. published a normative data-
base for isometric peak moment values for 27 motor
tasks based on a sample of 315 healthy French men and
women of 20–80 years of age [70].
Several fundamental caveats need to be considered
when trying to establish and apply such normative
values for comparability of assessment variables between
individuals. For instance, a fundamental problem is that
muscle function should be normalized to the design pa-
rameters of the individual’s musculoskeletal system
(Table 1), which are often not known. In practice, the
measured values should at least be normalized for body
mass or lean mass. Another issue is that in order to
compare the measured values of muscle function with
Fig. 2 Schematic 5-min all-out test to determine critical force or critical
moment. Dots represent 60 maximal intended isometric muscle actions
for a given motor task with a 60% duty cycle (3 s force exertion, 2 s rest).
The achieved end-test force or end-test moment corresponds to the
critical force and critical moment, respectively, which are indicative of an
individual’s neuromuscular fatigue threshold
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normative data, the data must have been obtained under
the same experimental conditions (standardization prob-
lem). Furthermore, it should be ascertained for each
motor task whether the obtained assessment variables are
heteroscedastic (increasing variability with increasing
values) or homoscedastic. In this context, it has been
shown both in orthopedic patients and healthy individuals
that repeated grip “strength” trials with submaximal and
maximal effort produce homoscedastic data sets [71]. The
data showed that larger mean moments did not yield lar-
ger standard deviations (SD) and that the lack of propor-
tional change between the means and SD exists for both
within-subject and between-subject grip strength scores
[71]. Thus, care must be exercised when the coefficient of
variation (CV, a measure for relative variability) is used to
interpret results from “tracking ability” or “force steadi-
ness” assessments. This is because weaker patients will
show biased outcomes expressed as inflated CVs.
Up to date, there exist no normative values for peak
force obtained by upper limb robotic assessments. Also,
the upper limb motor task eliciting the highest peak
force (i.e. maximum force) for a given target muscle
(group) is unknown. Similarly, reference values for force
direction, mechanical work, critical force (or moment),
fatigue, and impulse are currently missing.
Discussion and Conclusions
Recommendations for measurement
Compliance
Any compliance or deformability within the robotic sys-
tem may affect joint angle and velocity and lead to force
attenuation. Such effects are undesired since they may
confound the measurement outcomes [72]. With respect
to the effect of compliance on the joint angle, the external
(robot) moment is measured around a fixed axis of rota-
tion assuming that the tested joint axis is always in align-
ment with this. However, there is usually misalignment of
the joint and the device axes of rotation. The misalign-
ment originates from the compliance of the performer’s
soft tissues and the device’s paddings, leading to a non-
rigid connection between the performer’s body segments
and the robot/dynamometer arm and seat. The non-rigid
connection in turn facilitates movement of the segment
relative to the robot [73]. To minimize this, it is proposed
that joint and robot/dynamometer axes are aligned under
active (submaximal isometric) and not passive conditions,
near the primary joint angle of interest and separately for
reciprocal actions (e.g. extension and flexion) and/or to
correct for axis misalignment [73]. Furthermore, the com-
ponents of the measurement device should be as stiff
(high Young’s modulus) as possible to minimize force at-
tenuation, but without causing discomfort or pain to the
performer. Consideration of these factors should also help
to reduce baseline noise amplitude and thus improve the
detection of muscle action onset.
Force tasks vs. position tasks
The neuromuscular mechanisms responsible for the de-
cline in force during a fatiguing isometric elbow flexor
muscle action depend on the specific demands of the task
being performed, such as relative force magnitude and
load compliance [74, 75]. With respect to load compli-
ance, two types of motor tasks can be distinguished: One
type of task, a so-called “force task” requires the performer
to exert force against a rigid force transducer under iso-
metric conditions and to match a defined submaximal tar-
get force. The other task, a so-called “position task”,
requires the performer to keep the joint at a defined angle
during an isometric action while supporting an equivalent
inertial load (“compliant”). Based on appropriate feedback
signals, the performer is instructed to “maintain force”
during the force task and to “maintain position” during
the position task. However, in both cases the performer
exerts the identical net external moment.
It has been shown that for target forces up to 30% of
maximal intended force (“maximal voluntary contrac-
tion”, MVC) the time to task failure is briefer for a pos-
ition task than for a force task. Conversely, endurance
time for a force task is typically up to twice as long as
for the position task at the same target forces [74, 75].
These results indicate that the capacity to perform a fa-
tiguing isometric muscle action with a compliant load
that is ≤30% of maximal intended force is less than that
when exerting a comparable net external moment
against a rigid restraint.
Table 1 Basic Musculoskeletal Design Parameters Affecting
Muscle Function
Muscle Property Affected Design Parameter
Maximum force, tension, and
moment
Physiological cross sectional area
(number of parallel sarcomeres)
Areal distribution of muscle fiber types
Force Pennation angle
Fatigability Fiber type distribution (number and
area)
Maximum moment Moment arm
Velocity of excursion Muscle fiber length (total number of
serial sarcomeres)
Areal distribution of muscle fiber types
Submaximum force at given
shortening velocity
Muscle fiber length
Range of Motion Muscle fiber length
Tendon length
Damping, energy storage Tendon length
Relative stiffness of a muscle-
tendon unit
Tendon length/muscle fiber length
Relative muscle-joint
properties
Fiber length/moment arm
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Instruction and feedback
Force measurements depend on the instructions given
to the performers prior to force exertion [76, 77]. If the
assessment aims at achieving the highest possible im-
pulse (i.e. the highest possible RFD), then the performer
should be instructed to exert force “as fast and hard” as
possible with an emphasis on the explosiveness of the
rising phase of the force curve. If the goal is to achieve
peak force or peak moment the verbal instruction should
be to exert force “as hard as possible”. Thus, the meas-
urement of maximal intended force should be separated
from the measurement of impulse whenever this is
possible.
Similarly, the limit of task tolerance (time to task fail-
ure) may depend on the feedback and motivational cues
given during the task. Thus, feedback and motivation
should be standardized, too. Besides affecting the meas-
urement value, accurate and standardized instructions
are equally important to achieve a good retest reliability.
Normalization
Body size and body composition are factors well known
to exert a substantial influence on absolute force and
moment. Hence, for comparing individuals or groups of
differing body size the measured values should be at
least normalized. Different normalization approaches
exist, albeit the allometric formula Fn = F/(m
b/kg) with
Fn = normalized force or moment, F = measured force
or moment, m = body mass or fat-free mass, and b = allo-
metric scaling exponent, is recommended to obtain a
normalized index for force and moment [78]. It has been
suggested that for relatively homogenous healthy lean
populations, allometric scaling exponents of 0.66 and 1.0
for force and moment, respectively, are appropriate [79].
For more adipose populations lower body mass expo-
nents appear more suitable (0.45 and 0.68 for force and
moment, respectively) [79]. Nevertheless, Folland et al.
recommend fat-free mass as index for scaling force and
moment to body size, and higher allometric scaling ex-
ponents are advocated in this case (0.76 and 1.12 for
force and moment, respectively) [79].
Reliability
Retest reliability refers to the reproducibility of values of
a test, assay or other measurement when the measure-
ment is repeated in trials on the same individuals [80].
Hence, reliability concerns the monitoring of individuals
for real changes, the estimation of sample size for ex-
perimental studies and the assessment of competing
brands of equipment or varying technologies. Therefore,
it is important to characterize the reliability of assess-
ment measures in a standardized way, for instance by
reporting the observed values and confidence limits of
the typical error and changes in the mean [80].
Furthermore, to be reproducible and comparable between
centers worldwide, the described assessment parameters
need to be reported explicitly. These parameters include,
for instance, familiarization, joint axes alignment methods
(positioning and fixation), correction techniques, instruc-
tion and feedback, detection method of muscle action on-
set, sampling of the force signal, filtering, and calculation
of results (averaging etc.).
“Pre-tension” and antagonist force (countermovement)
Active muscle force (“pre-tension”) prior to the onset of
peak force or RFD (impulse) assessments can influence
the attained peak force and peak RFD, respectively.
Whereas the magnitude of peak moment is increased
with pre-tensions up to 40% peak torque in elderly men
and women, peak RFD is decreased when active force is
present prior to the onset of an impulsive action [81,
82]. Similarly, it appears that the magnitude, duration
and speed of force exertion by the antagonist muscle(s)
immediately prior to the onset of the agonist(s) action
may influence both RFD and peak moment [83, 84].
Therefore, it is advisable to standardize pre-tension
conditions across trials, individuals and sessions to ob-
tain reliable measures of peak force and RFD. One pos-
sible solution may be to show the baseline force on a
high-resolution scale in real time during the assessment
and to provide feedback to the performer in order to
guarantee a stable baseline force.
Conclusion
Robotic devices allow for sensible and reliable quantifi-
cation of motor function. We give an overview of the
existing assessment approaches of arm force with ro-
botic devices and provide possible physiological end-
points for measurements. Furthermore, we propose a
battery of meaningful robotic assessments for the upper
extremity that take advantage of the control and sensor
abilities of robotic devices. The suggested parameters
encompass force magnitude (peak and maximum), force
direction, moment of a force, impulse, and critical force.
We believe that these parameters provide detailed in-
sights into arm motor function of both healthy and pa-
tients and should be included into robotic assessments
of the arm. They may give new insights into the course
of diseases and broaden our understanding of
pathologies.
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